Ryan J.Andreoli

Partner

(T) 1.212.326.3494

Ryan Andreoli is a seasoned commercial litigator with more than 14 years of experience representing financial institutions and other large corporations in securities class actions, shareholder derivative matters, valuation disputes, and regulatory investigations. He has represented clients in a variety of state and federal courts across the country and before regulators including the SEC and CFTC.

Ryan has worked on matters involving a wide variety of financial products, including CMBS, RMBS, credit default swaps, interest rate swaps, and total return swaps. He also has experience representing parties and financial advisors in M&A litigation and advising clients on how to respond to shareholder demands. Ryan has significant trial experience, including representing a defense contractor in a multiweek jury trial involving claims for breach of contract and fraud and the Lehman Brothers Estate in a multiweek bench trial involving the valuation of a portfolio of derivatives.

Ryan has an active pro bono practice, including representing clients in immigration and disability benefits proceedings and submitting amicus briefs on behalf of nonprofit organizations on issues such as low-income housing and prisoners' rights.

Experience

  • Citizens Financial Group secures dismissals of putative class action claimsJones Day client Citizens Financial Group Inc. (“Citizens”) secured dismissals of putative class action complaints brought by two shareholders who claim that Citizens violated the Securities Exchange Act of 1934 by making alleged misstatements regarding the extent to which customer appointments were made or kept.
  • Harman International Industries defends securities class actionJones Day represents Harman International Industries, Incorporated and certain of its officers and directors in a securities fraud class action lawsuit pending in the District of Columbia.
  • The following represents experience acquired prior to joining Jones Day.

    Represented a large pharmaceutical company and certain of its officers and directors in securities, shareholder derivative, and ERISA actions relating to the marketing and sale of two arthritis drugs.

    Represented a multibillion dollar hedge fund in an SEC investigation into trading and disclosure practices.

    Represented a large financial institution in litigation involving claims that it breached an oral contract requiring it to convey its interest in a mezzanine loan to the borrower.

    Represented a real estate investment firm in litigation commenced by a junior loan participant in connection with a contemplated sale of the loan.

    Represented a biotechnology company in class actions brought by shareholders in three different jurisdictions seeking to enjoin the company's proposed acquisition of a competitor.

    Represented a nuclear fuel producer in litigation asserting that it violated RICO by failing to perform certain contractual obligations.

    Represented a military defense contractor in litigation alleging misappropriation of trade secrets and breach of contract by a former employee.

    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.